Allogene Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q4 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Allogene Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2017 to Q4 2024.
  • Allogene Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $994K.
  • Allogene Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $16.1M, a 3301% increase year-over-year.
  • Allogene Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $16.1M, a 3301% increase from 2023.
  • Allogene Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $472K.
  • Allogene Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$4.88M, a 162% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $994K +$1.66M Dec 31, 2024 10-K 2025-03-13
Q3 2024 $5.48M +$4.77M +673% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $5.07M +$3.77M +288% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $4.5M +$5.38M Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$669K +$211K +24% Dec 31, 2023 10-K 2025-03-13
Q3 2023 $709K +$2.44M Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $1.31M +$4.98M Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$876K -$2.28M -162% Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$880K +$742K +45.7% Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$1.73M -$1.22M -235% Sep 30, 2022 10-K 2024-03-14
Q2 2022 -$3.67M -$3.77M -4051% Jun 30, 2022 10-K 2024-03-14
Q1 2022 $1.41M +$1.22M +656% Mar 31, 2022 10-K 2024-03-14
Q4 2021 -$1.62M +$63.7M +97.5% Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$516K -$2.36M -128% Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $93K -$2.09M -95.7% Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $186K -$3.02M -94.2% Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$65.4M -$68.8M -2028% Dec 31, 2020 10-K/A 2024-03-14
Q3 2020 $1.84M -$2.47M -57.2% Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.18M -$2.38M -52.1% Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $3.2M -$1.62M -33.6% Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $3.39M Dec 31, 2019 10-K 2022-02-23
Q3 2019 $4.31M +$25.6M Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $4.56M Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $4.83M Mar 31, 2019 10-Q 2020-05-06
Q3 2018 -$21.3M Sep 30, 2018 10-Q 2018-11-21
Q4 2017 $0 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.